Othisis Medtech
US healthcare software — an ambient AI medical scribe. A technical B2B audience and a compliance-sensitive category.
- Location
- USA
- Sector
- Healthcare technology
- What we did
- Search engine optimisation, Google Ads
Who they are
Othisis Medtech builds an ambient AI medical scribe — software that listens to a patient visit and produces structured clinical documentation, including SOAP notes, summaries and referral letters, with each element traceable back to the original transcript.
Their positioning is deliberately narrow: administrative support for clinicians rather than clinical decision-making, with an explicit rejection of black-box AI.
What we were doing
Organic search and Google Ads for a software product sold to clinicians and medical practices in the United States — a market where the audience is technically literate, sceptical by training, and operating under HIPAA.
Search that matches how clinicians actually evaluate software
Buyers in this category search by problem ("reduce documentation time"), by comparison, and by compliance question. Those are three different intents needing three different kinds of page, and the comparison and compliance searches are where the buying decisions get made.
Careful claim language
Healthcare software marketing sits close to regulated territory. Copy had to stay on the right side of the line between describing what the product does and implying a clinical outcome — a constraint that shaped the search work as much as the writing.
Paid search on narrow, high-intent terms
A small, specific audience makes broad targeting expensive and useless. The Google Ads work stayed tight to terms with genuine evaluation intent rather than chasing volume.
Services on this project
- Search engine optimisation — Most sites we audit lose more traffic to fixable on-page problems than to any competitor.
- Google Ads — Management fee separate from ad spend. You own the account. Always.
- Healthcare & Hospitals — how we approach this sector
We publish no performance figures we cannot evidence and have not been given permission to share — see why that is.
Send us your URL. We’ll tell you what we’d fix.
Tell us what you sell and who you’re up against. We’ll come back with what we think is costing you the most traffic, what fixing it involves and what it’s likely to cost — before you commit to anything.